标题
Home
About Us
Company Introduction
Team Introduction
Quality System
Contact Us
Process Development
Process Development and Optimization
Analytical Method Development and Validation
Stability studies
Formulation and aseptic filling, lyophilization
Oligo Manufacturing
Preclinical Development, Research-Grade
Clinical Phase I-III Production
Early Commercial Phase
GMP Compliance
GMP Facilities and Equipment
EHS System
Collaborations
Case Study
Other Service
IND Application Dossiers
The Melting Temperature (Tm) Test
Formulation Development and Production
EN
CN
News
Get up to date with the latest HitGen articles and join us in the events
News
Press Release
Coverage
Events
Industry News
News
标题
Venture forces invest millions in new type of treatment for particularly aggressive form of cancer
Release time:2023-10-19
Previous:
Infographic | HitGen FY2023 Q3 Report
Next:
SGC and HitGen Announce Research Collaboration Focused on DNA-Encoded Library Based Drug Discovery
Home
/
News
/
Press Release
/
Venture forces invest millions in new type of treatment for particularly aggressive form of cancer